Kairos Pharma (KAPA) Total Liabilities (2023 - 2025)
Kairos Pharma's (KAPA) quarterly Total Liabilities came in at $6.5 million in Q4 2025, up 559.27% YoY from $992000.0 in Q4 2024, and down 1.99% on a QoQ basis from $6.7 million in Q2 2025.
Kairos Pharma (KAPA) Total Liabilities (2023 - 2025) Analysis & Trends
Kairos Pharma (KAPA) has 3 years of Total Liabilities data on file, last reported at $6.5 million in Q4 2025.
- Quarterly Total Liabilities rose 559.27% year-over-year to $6.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.5 million (up 559.27% YoY) and the FY2025 annual result came in at $6.5 million, up 559.27% from the prior year.
- Total Liabilities declined to $6.5 million in Q4 2025, from $6.7 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $7.9 million in Q1 2025 to a low of $992000.0 in Q4 2024.
- A 3-year average of $4.5 million and a median of $4.8 million in 2023 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2024 — Total Liabilities plunged 67.4% — and 2025, when it jumped 559.27%.
- Tracing KAPA's Total Liabilities over 3 years: stood at $3.0 million in 2023, then sank by 67.4% to $992000.0 in 2024, then jumped by 559.27% to $6.5 million in 2025.
- The last three Total Liabilities figures came in at $6.5 million (Q4 2025), $6.7 million (Q2 2025), and $7.9 million (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 4.20 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 4.00 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 4.20 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 1.35 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 10.03 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 3.22 Bn |
| 10 | Kairos Pharma | 5.50 Mn | 168,380.07 | - | 6.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.54 Mn |
| Jun 30, 2025 | 6.67 Mn |
| Mar 31, 2025 | 7.94 Mn |
| Dec 31, 2024 | 992,000.00 |
| Sep 30, 2024 | 1.67 Mn |
| Dec 31, 2023 | 3.04 Mn |